Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene
- 1 February 2003
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 13 (2) , 151-157
- https://doi.org/10.1016/s0960-8966(02)00218-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Workshop report of the 89th ENMC International Workshop: Central Core Disease, 19th–20th January 2001, Hilversum, The NetherlandsNeuromuscular Disorders, 2002
- Segregation of malignant hyperthermia, central core disease and chromosome 19 markersBritish Journal of Anaesthesia, 1999
- A severe clinical and pathological variant of central core disease with possible autosomal recessive inheritanceNeuromuscular Disorders, 1998
- The role of immunocytochemistry in congenital myopathiesNeuromuscular Disorders, 1998
- Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.Proceedings of the National Academy of Sciences, 1993
- Assignment of the gene for central core disease to chromosome 19Human Genetics, 1990
- Localization of the malignant hyperthermia susceptibility locus to human chromosome 19ql2–13.2Nature, 1990
- Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermiaNature, 1990
- Central Core DiseaseMedicine, 1987
- Central core disease. A correlated genetic, histochemical, ultramicroscopic, and biochemical study.Journal of Neurology, Neurosurgery & Psychiatry, 1975